An overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Vascular dementia, which occurs after a stroke, is the second most common dementia type (after Alzheimer’s).
In addition to a thorough introduction to frontotemporal dementias, The Association for Frontotemporal Dementias provides specific diagnostic and clinical information for a variety of disorders, including Pick's Disease and progressive aphasia.
In addition to publishing a newsletter and hosting email support groups for care-givers and spouses of Lewy Body Dementia patients, the LBDA Web site contains patient care tips and links to scientific journal articles about LBD.
This page provides a succinct description of Lewy Body Dementia, as well as information about clinical trials.
The National Institute of Neurological Disorders and strokes briefly describes Pick's Disease and provides links to relevant clinical trials.
This University of California, San Francisco site offers information on different forms of dementia, along with healthy aging and memory.
(Read Q&A with Lary C. Walker Ph.D.)
Studying how proteins such as PrP, amyloid beta, tau, and others aggregate and spread, and kill brain cells, represents a crucial new frontier in neuroscience for Alzheimer's, Parkinson's, CTE, and ALS.
Recent research provides strong evidence that
pollutants cause harms, and suggests underlying pathways and mechanisms.
Purpose in Life (PIL) is a research area that focuses on the interactions between mind and body and the powerful ways in which emotional, mental, social, and spiritual factors can directly affect health. It links the belief that your life has meaning and purpose to a robust and persistently improved physiological health outcome—particularly as a way to treat dementia, spinal cord injuries, stroke, and immunological and cardiovascular issues that include but extend beyond the brain. An interview with Adam Kaplin, MD, PhD, one of the co-authors of the May 2015 Cerebrum essay on PIL.
Kenneth S. Kosik, MD, was a member of one of several research groups that originally discovered tau protein in the Alzheimer’s neurofibrillary tangle. In this month’s Cerebrum feature, “ Tau-er of Power,” he points out that if he and other tau researchers can better understand tau, then progress can be made in fighting neurological disorders linked to this protein, including frontotemporal dementia, chronic traumatic encephalopathy (CTE), and Alzheimer’s disease.
Studies suggest amyloid accumulates for 3
decades or more before dementia symptoms show.
new insights into how the tau protein spreads within and harms the brain, in
Alzheimer’s and other diseases--and tau-targeting therapies are now entering